SE536793C2 - Detektion av kolhydrater - Google Patents
Detektion av kolhydrater Download PDFInfo
- Publication number
- SE536793C2 SE536793C2 SE1250751A SE1250751A SE536793C2 SE 536793 C2 SE536793 C2 SE 536793C2 SE 1250751 A SE1250751 A SE 1250751A SE 1250751 A SE1250751 A SE 1250751A SE 536793 C2 SE536793 C2 SE 536793C2
- Authority
- SE
- Sweden
- Prior art keywords
- phta
- carbohydrates
- carbohydrate
- lco
- signal
- Prior art date
Links
- 150000001720 carbohydrates Chemical class 0.000 title claims description 220
- 238000001514 detection method Methods 0.000 title claims description 46
- 235000014633 carbohydrates Nutrition 0.000 claims description 219
- 150000001875 compounds Chemical class 0.000 claims description 126
- 239000001913 cellulose Substances 0.000 claims description 62
- 229920002678 cellulose Polymers 0.000 claims description 62
- 238000000034 method Methods 0.000 claims description 47
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 16
- 229960002897 heparin Drugs 0.000 claims description 16
- 229920002527 Glycogen Polymers 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 229940096919 glycogen Drugs 0.000 claims description 15
- 229920000669 heparin Polymers 0.000 claims description 14
- 229920000856 Amylose Polymers 0.000 claims description 13
- 229920002101 Chitin Polymers 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 11
- 229920002498 Beta-glucan Polymers 0.000 claims description 10
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 10
- 238000011002 quantification Methods 0.000 claims description 10
- 230000003287 optical effect Effects 0.000 claims description 9
- 150000004676 glycans Chemical class 0.000 claims description 8
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 7
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 7
- 238000001727 in vivo Methods 0.000 claims description 7
- 238000011065 in-situ storage Methods 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 238000000338 in vitro Methods 0.000 claims description 5
- 150000002772 monosaccharides Chemical class 0.000 claims description 5
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 230000002503 metabolic effect Effects 0.000 claims description 4
- 239000002858 neurotransmitter agent Substances 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 2
- 239000013067 intermediate product Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 description 124
- 235000010980 cellulose Nutrition 0.000 description 61
- 230000005284 excitation Effects 0.000 description 42
- 238000004458 analytical method Methods 0.000 description 40
- 230000008859 change Effects 0.000 description 34
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 24
- 241000144542 Pentamera Species 0.000 description 23
- 238000000695 excitation spectrum Methods 0.000 description 23
- 238000010790 dilution Methods 0.000 description 22
- 239000012895 dilution Substances 0.000 description 22
- 230000003595 spectral effect Effects 0.000 description 16
- 239000000725 suspension Substances 0.000 description 15
- 229930192474 thiophene Natural products 0.000 description 15
- 238000012544 monitoring process Methods 0.000 description 14
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000001257 hydrogen Substances 0.000 description 12
- 229910052739 hydrogen Inorganic materials 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 11
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 11
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 11
- 239000000306 component Substances 0.000 description 11
- 238000000295 emission spectrum Methods 0.000 description 11
- 210000002744 extracellular matrix Anatomy 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 235000010413 sodium alginate Nutrition 0.000 description 11
- 239000000661 sodium alginate Substances 0.000 description 11
- 229940005550 sodium alginate Drugs 0.000 description 11
- 230000032770 biofilm formation Effects 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 150000002431 hydrogen Chemical class 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000012010 growth Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000008358 core component Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 229920001503 Glucan Polymers 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000012921 fluorescence analysis Methods 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 239000003068 molecular probe Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 150000003577 thiophenes Chemical class 0.000 description 4
- 239000002023 wood Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- -1 carbohydrate compounds Chemical class 0.000 description 3
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001506 fluorescence spectroscopy Methods 0.000 description 3
- 238000011194 good manufacturing practice Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000002135 phase contrast microscopy Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 102000009091 Amyloidogenic Proteins Human genes 0.000 description 2
- 108010048112 Amyloidogenic Proteins Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 239000003216 Oxystearin Substances 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000004845 protein aggregation Effects 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 239000002970 Calcium lactobionate Substances 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 229940127321 Structural Macromolecules Drugs 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 206010002022 amyloidosis Diseases 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 235000021485 packed food Nutrition 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000001797 sucrose acetate isobutyrate Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1250751A SE536793C2 (sv) | 2012-07-02 | 2012-07-02 | Detektion av kolhydrater |
| CA2877470A CA2877470C (en) | 2012-07-02 | 2013-06-27 | Carbohydrate detection |
| NO13813945A NO2867673T3 (enExample) | 2012-07-02 | 2013-06-27 | |
| AU2013285614A AU2013285614B2 (en) | 2012-07-02 | 2013-06-27 | Carbohydrate detection |
| JP2015520123A JP6317342B2 (ja) | 2012-07-02 | 2013-06-27 | 炭水化物の検出 |
| US14/408,440 US9958439B2 (en) | 2012-07-02 | 2013-06-27 | Carbohydrate detection |
| PCT/SE2013/050810 WO2014007730A1 (en) | 2012-07-02 | 2013-06-27 | Carbohydrate detection |
| IN10649DEN2014 IN2014DN10649A (enExample) | 2012-07-02 | 2013-06-27 | |
| PL13813945T PL2867673T3 (pl) | 2012-07-02 | 2013-06-27 | Wykrywanie węglowodanów |
| BR112014032974-5A BR112014032974B1 (pt) | 2012-07-02 | 2013-06-27 | Método para detecção, identificação e/ou quantificação de um ou mais carboidratos e uso de um oligotiofeno conjugado luminescente |
| EP13813945.6A EP2867673B1 (en) | 2012-07-02 | 2013-06-27 | Carbohydrate detection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1250751A SE536793C2 (sv) | 2012-07-02 | 2012-07-02 | Detektion av kolhydrater |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE1250751A1 SE1250751A1 (sv) | 2014-01-03 |
| SE536793C2 true SE536793C2 (sv) | 2014-08-19 |
Family
ID=49882344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE1250751A SE536793C2 (sv) | 2012-07-02 | 2012-07-02 | Detektion av kolhydrater |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9958439B2 (enExample) |
| EP (1) | EP2867673B1 (enExample) |
| JP (1) | JP6317342B2 (enExample) |
| AU (1) | AU2013285614B2 (enExample) |
| BR (1) | BR112014032974B1 (enExample) |
| CA (1) | CA2877470C (enExample) |
| IN (1) | IN2014DN10649A (enExample) |
| NO (1) | NO2867673T3 (enExample) |
| PL (1) | PL2867673T3 (enExample) |
| SE (1) | SE536793C2 (enExample) |
| WO (1) | WO2014007730A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016331156B2 (en) * | 2015-10-01 | 2022-03-03 | Richter Life Science Development Ab | Detection of microbial peptides |
| FR3050271B1 (fr) | 2016-04-18 | 2018-04-13 | Centre National De La Recherche Scientifique | Procede de sequencage d'oligosaccharides |
| DE102016113166B4 (de) * | 2016-07-18 | 2022-02-24 | Joanneum Research Forschungsgesellschaft Mbh | Verfahren zum Nachweis eines Biofilms und Mittel zum Nachweis eines Biofilms |
| SE543571C2 (en) * | 2019-02-07 | 2021-03-30 | Christian Strietzel | Conducting redox oligomers |
| JP2020165847A (ja) * | 2019-03-29 | 2020-10-08 | 株式会社島津製作所 | 食品の品質判定方法、及び、食品品質判定装置 |
| US20230151405A1 (en) * | 2020-04-15 | 2023-05-18 | The Penn State Research Foundation | Biodegradable dna-alginate conjugate for reversible protein and cell labeling and imaging |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1692299B1 (en) | 2003-10-31 | 2009-07-29 | Immunetics, Inc. | Rapid peptidoglycan-based assay for detection of bacterial contamination of platelets |
| WO2007075595A2 (en) | 2005-12-20 | 2007-07-05 | Vertex Pharmacueticals Incorporated | Biofilm assay |
| ES2551744T3 (es) | 2008-10-17 | 2015-11-23 | Neuroscios Gmbh | Nuevos compuestos de tiofeno para uso en terapia |
| CN102770428B (zh) * | 2010-02-16 | 2015-07-29 | 赛拉米诺瓦公司 | 作为分子探针的寡聚噻吩衍生物 |
| GB201020236D0 (en) * | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
-
2012
- 2012-07-02 SE SE1250751A patent/SE536793C2/sv not_active IP Right Cessation
-
2013
- 2013-06-27 CA CA2877470A patent/CA2877470C/en active Active
- 2013-06-27 BR BR112014032974-5A patent/BR112014032974B1/pt active IP Right Grant
- 2013-06-27 WO PCT/SE2013/050810 patent/WO2014007730A1/en not_active Ceased
- 2013-06-27 JP JP2015520123A patent/JP6317342B2/ja active Active
- 2013-06-27 PL PL13813945T patent/PL2867673T3/pl unknown
- 2013-06-27 IN IN10649DEN2014 patent/IN2014DN10649A/en unknown
- 2013-06-27 US US14/408,440 patent/US9958439B2/en active Active
- 2013-06-27 AU AU2013285614A patent/AU2013285614B2/en active Active
- 2013-06-27 EP EP13813945.6A patent/EP2867673B1/en active Active
- 2013-06-27 NO NO13813945A patent/NO2867673T3/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2867673B1 (en) | 2017-12-06 |
| PL2867673T3 (pl) | 2018-07-31 |
| JP6317342B2 (ja) | 2018-04-25 |
| BR112014032974B1 (pt) | 2021-09-14 |
| AU2013285614B2 (en) | 2018-10-18 |
| BR112014032974A2 (pt) | 2017-06-27 |
| SE1250751A1 (sv) | 2014-01-03 |
| AU2013285614A1 (en) | 2015-01-22 |
| JP2015524552A (ja) | 2015-08-24 |
| CA2877470C (en) | 2022-07-19 |
| EP2867673A1 (en) | 2015-05-06 |
| CA2877470A1 (en) | 2014-01-09 |
| IN2014DN10649A (enExample) | 2015-09-11 |
| US9958439B2 (en) | 2018-05-01 |
| US20150212076A1 (en) | 2015-07-30 |
| EP2867673A4 (en) | 2016-03-02 |
| WO2014007730A1 (en) | 2014-01-09 |
| NO2867673T3 (enExample) | 2018-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | A novel colorimetric aptasensor for detection of chloramphenicol based on lanthanum ion–assisted gold nanoparticle aggregation and smartphone imaging | |
| SE536793C2 (sv) | Detektion av kolhydrater | |
| Xu et al. | Aptamer based SERS detection of Salmonella typhimurium using DNA-assembled gold nanodimers | |
| Meng et al. | Ultrasensitive SERS aptasensor for the detection of oxytetracycline based on a gold-enhanced nano-assembly | |
| CN106970061B (zh) | 碳点/铜纳米簇复合物比率荧光多巴胺探针的制备方法 | |
| Sang et al. | Aminophenylboronic-acid-conjugated polyacrylic acid–Mn-doped ZnS quantum dot for highly sensitive discrimination of glycoproteins | |
| Si et al. | Rapid and accurate detection of Escherichia coli growth by fluorescent pH-sensitive organic nanoparticles for high-throughput screening applications | |
| Zhang et al. | Detection of biomarkers in body fluids using bioprobes based on aggregation-induced emission fluorogens | |
| Mangini et al. | Interaction of nanoparticles with endotoxin Importance in nanosafety testing and exploitation for endotoxin binding | |
| Cui et al. | Near-infrared carbon dots for cell imaging and detecting ciprofloxacin by label-free fluorescence sensor based on aptamer | |
| CN105693703B (zh) | 一种用于细胞内溶酶体pH成像的新型比率型荧光探针 | |
| CN107014787B (zh) | 谷胱甘肽模板金纳米簇在检测半胱氨酸和赖氨酸中的应用 | |
| Liu et al. | Single gold nanoparticle localized surface plasmon resonance spectral imaging for quantifying binding constant of carbohydrate–protein interaction | |
| CN103207166A (zh) | 用于快速检测atp的荧光共振体系的制备方法 | |
| Yao et al. | Rapid and sensitive detection of Hg 2+ with a SERS-enhanced lateral flow strip | |
| Jana et al. | Detection of sialic acid and imaging of cell-surface glycan using a fluorescence–SERS dual probe | |
| Richter-Dahlfors et al. | Fluorescent optotracers for bacterial and biofilm detection and diagnostics | |
| Jiang et al. | Simple and fast colorimetric detection of lipopolysaccharide based on aptamer and SYBR Green I mediated aggregation of gold nanoparticles | |
| Ge et al. | Utilizing hyaluronic acid as a versatile platform for fluorescence resonance energy transfer-based glucose sensing | |
| CN107941773B (zh) | 一种基于荧光分子的内毒素的检测方法 | |
| CN108279222B (zh) | 一种双波长共振瑞利散射法测定壳聚糖含量的方法 | |
| CN107957403B (zh) | 一种以胭脂红为探针的紫外分光光度法测定壳聚糖含量的方法 | |
| CN108088830A (zh) | 一种通过共振瑞利散射法准确测定壳寡糖含量的方法 | |
| Zhang et al. | Boronic functionalized aptamer macroarrays with dual-recognition and isothermal amplification of lipopolysaccharide detection | |
| Li et al. | A novel self-ratiometric fluorescent sensor of sodium alginate hydrogel bead doping with coumarin derivative with extremely acidic pH visual monitoring of fruit juice freshness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |